Nivolumab and ipilimumab with tumour-infiltrating lymphocytes to treat triple-negative breast cancer

A new era of early cancer detection with blood test may change cancer screening paradigms

New era of early cancer detection blood tests on the horizon

Sacituzumab govitecan continues to improve OS for ET-resistant HR+/HER2-mBC, and QoL update

HER2-low mBC patients report preserved QOL with trastuzumab deruxtecan

Lasofoxifene shows promise for women with ESR1-mutated mBC

Extended adjuvant AI not advised for HPBC after 5+ yrs of sequential endocrine therapy

Prognostic model of all-cause mortality at 30 days in patients with cancer and COVID-19

Metastatic breast cancer endpoints for survival: rwPFS and TTNT

New data presented at ESMO for multi-cancer early detection

Olaparib continues to show positive results in advanced ovarian cancer - 7 year data

OncoAlert and ecancer weekly round up for August 15th - 21st, 2022